Patent Yard Sign in
Canadian application, no grantCanada

A human ribonucleotide reductase m2 subunit

CA 2513149 A1 · Owner: Yen, Yun · Inventors: Yen, Yun

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

An isolated nucleic acid containing a human ribonucleotide reductase M2 subunit promoter sequence or genomic sequence. Also disclosed are methods of determining whether a subject is suffering from or at risk for developing a cell proliferation-associated disorder identifying a compound for treating a cell proliferation-associated disorder treating a cell proliferation-, associated disorder and developing a procedure for treating a cell proliferation-associated disorder.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 25, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 25, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 25, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 25, 2003
GrantedNo grant recorded
Term endedMarch 25, 2023
Patent numberCA 2513149 A1
Classification (IPC)C07H21/02 +2 more

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedMarch 25, 2003Term endedMarch 25, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.